Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

Схожие документы

• Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients
  по: Xu, Xiaoling, et al.
  Опубликовано: (2020)
• Effective treatment of severe COVID-19 patients with tocilizumab
  по: Xu, Xiaoling, et al.
  Опубликовано: (2020)
• Why tocilizumab could be an effective treatment for severe COVID-19?
  по: Fu, Binqing, et al.
  Опубликовано: (2020)
• Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
  по: Wang, Dongsheng, et al.
  Опубликовано: (2021)
• Tocilizumab is recommended for the treatment of severe COVID-19
  по: Yonggang Zhou, et al.
  Опубликовано: (2020-11-01)